Greenbrook TMS Announces Dates for Its Third Quarter 2021 Financial Results

Rhea-AI Summary

Greenbrook TMS Inc. (NASDAQ: GBNH) is set to release its third quarter 2021 operational and financial results on November 9, 2021, after market hours. A conference call will follow on November 10, 2021, at 10:00 a.m. ET, featuring CEO Bill Leonard and CFO Erns Loubser to discuss the results. Greenbrook operates 148 treatment centers providing Transcranial Magnetic Stimulation (TMS) therapy, a non-invasive treatment for depression, having delivered over 675,000 TMS treatments to over 19,000 patients.

TORONTO--(BUSINESS WIRE)-- Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its third quarter 2021 operational and financial results after market hours on November 9, 2021.

THIRD QUARTER 2021 CONFERENCE CALL DETAILS

Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 a.m. (Eastern Time) on November 10, 2021 to discuss the financial results for the quarter.

Dial in Numbers:

Toll Free North America: (866) 521-4909
Toronto: (647) 427-2311

Webcast:

For more information or to listen to the call via webcast, please visit:
https://www.greenbrooktms.com/investors/events

For those that plan on accessing the conference call or webcast, please allow ample time prior to the call time.

Conference Call Replay:

Toll Free (North America): (800) 585-8367
Toronto: (416) 621-4642
Conference ID: 1266033

The conference call replay will be available from 1:00 p.m. ET on November 10, 2021, until 11:59 p.m. ET on December 10, 2021.

About Greenbrook TMS Inc.

Operating through 148 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 675,000 TMS treatments to over 19,000 patients struggling with depression.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211028006074/en/

Glen Akselrod

Investor Relations

Greenbrook TMS Inc.

Contact Information:

investorrelations@greenbrooktms.com

1-855-797-4867

Source: Greenbrook TMS Inc.

FAQ

When will Greenbrook TMS release its third quarter 2021 results?

Greenbrook TMS Inc. will release its third quarter 2021 operational and financial results on November 9, 2021.

What time is the Greenbrook TMS conference call scheduled?

The conference call is scheduled for November 10, 2021, at 10:00 a.m. Eastern Time.

Who will host the Greenbrook TMS conference call?

The conference call will be hosted by CEO Bill Leonard and CFO Erns Loubser.

How many treatment centers does Greenbrook TMS operate?

Greenbrook TMS operates 148 treatment centers across the United States.

What therapy does Greenbrook TMS provide?

Greenbrook TMS provides Transcranial Magnetic Stimulation (TMS) therapy for the treatment of Major Depressive Disorder and other mental health disorders.